Literature DB >> 10348299

p53 mutation decreased radiosensitivity in rat yolk sac tumor cell lines.

K Maebayashi1, N Mitsuhashi, T Takahashi, H Sakurai, H Niibe.   

Abstract

PURPOSE: We reported that two established rat yolk sac tumor cell lines differ in their radiosensitivity by 1.7 fold, and the variation is most likely manifested by the differences seen in their apoptotic response. We investigated the relationship between radiosensitivity and p53 in these cell lines. METHODS AND MATERIALS: We assessed the status of p53 in cell lines by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and sequence analysis, and also analyzed protein expression of p53, p21, and bax as a function of time after irradiation to determine the signal transduction for p53 by immunoblotting.
RESULTS: A band shift was observed only in exon 7 for the radioresistant NMT-1R cells and no band shift was detected for the radiosensitive NMT-1 cells. A band shift was confirmed also at the mRNA level. Exon 7 of p53 DNA showed a three base substitution of DNA at codon 267 to 268. Expression of p53, p21, and bax proteins in NMT-1R cells did not change after 10 Gy irradiation; however, in NMT-1 cells, the expression of these proteins was increased from 1-12 h after irradiation.
CONCLUSION: A loss of p53 function by radiation-induced mutation of p53 decreased the radiosensitivity in these cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348299     DOI: 10.1016/s0360-3016(99)00025-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.

Authors:  Nobuyuki Hinata; Toshiro Shirakawa; Zhujun Zhang; Akira Matsumoto; Masato Fujisawa; Hiroshi Okada; Sadao Kamidono; Akinobu Gotoh
Journal:  Urol Res       Date:  2003-09-04

2.  MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury.

Authors:  Cong Liu; Chuanfeng Zhou; Fu Gao; Shengyun Cai; Chao Zhang; Luqian Zhao; Fang Zhao; Fei Cao; Jing Lin; Yanyong Yang; Jin Ni; Jun Jia; Wei Wu; Li Zhou; Jianguo Cui; Wei Zhang; Bailong Li; Jianming Cai
Journal:  Int J Biol Sci       Date:  2011-03-02       Impact factor: 6.580

Review 3.  In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review.

Authors:  Qian Zhang; Lei Wu
Journal:  J Oncol       Date:  2022-02-21       Impact factor: 4.375

Review 4.  A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.

Authors:  Hossein Moutabian; Mehrsa Majdaeen; Ruhollah Ghahramani-Asl; Masoumeh Yadollahi; Esmaeil Gharepapagh; Gholamreza Ataei; Zahra Falahatpour; Hamed Bagheri; Bagher Farhood
Journal:  Cancer Cell Int       Date:  2022-04-02       Impact factor: 5.722

5.  Role of Radiotherapy in Recurrent Intra-Abdominal Yolk Sac Tumor.

Authors:  Marhendra Satria Utama; Andi Kurniadi; A A Citra Yunda Prahastiwi; Antony A Adibrata
Journal:  Case Rep Oncol       Date:  2021-06-28

6.  Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway.

Authors:  Weiming Duan; Yaxiang Xu; Yujin Dong; Lili Cao; Jian Tong; Xinwen Zhou
Journal:  J Radiat Res       Date:  2013-01-24       Impact factor: 2.724

7.  Successful radiotherapy in postoperative recurrence of a primary mediastinal yolk sac tumor: A case report.

Authors:  Masakuni Sakaguchi; Toshiya Maebayashi; Takuya Aizawa; Naoya Ishibashi; Shoko Fukushima; Tsutomu Saito
Journal:  Thorac Cancer       Date:  2015-08-20       Impact factor: 3.500

8.  A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities.

Authors:  Li-Feng Hu; Huan-Rong Lan; Xue-Min Li; Ke-Tao Jin
Journal:  Oxid Med Cell Longev       Date:  2021-08-22       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.